Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (41-50 of 190) with videos related to

Pageof 19
Sort By:
Atherosclerosis|September 6, 2017
GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomesYa-Lan Ying, Yung-Chih Chen, Karin Jandeleit-Dahm, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 1, 1993
The kissing balloons technique. Simultaneous dilatation of stenoses of branch arteries at the bifurcation of the renal arteryA Chavan, M Galanski, K Jandeleit, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1991
Angiotensin-converting enzyme in macro- and microvessels of the ratK Jandeleit, B Jackson, R Perich, et al.
Diabetes|November 23, 2013
Comment on: Sukumar et al. Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 2013;62:2130-2134Karin A M Jandeleit-Dahm, Harald H H W Schmidt
Clinical Science (London, England : 1979)|September 1, 2018
A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetesJay C Jha, Florence Ho, Christopher Dan, et al.
Biomedicines|February 27, 2026
Technological Innovations and the Translational Path of Kidney OrganoidsAnni Li, Zhonglin Chai, Karin Jandeleit-Dahm, et al.
Journal of Nephrology|May 25, 2020
Targeting oxidative stress and anti-oxidant defence in diabetic kidney diseaseJakob Appel Østergaard, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm
Current Opinion in Lipidology|January 13, 2009
Direct antiatherosclerotic effects of PPAR agonistsKarin A M Jandeleit-Dahm, Anna Calkin, Chris Tikellis, et al.
Antioxidants & Redox Signaling|February 4, 2020
NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic ComplicationsSofia Urner, Florence Ho, Jay C Jha, et al.
Advances in Chronic Kidney Disease|May 1, 2014
New insights into the use of biomarkers of diabetic nephropathyJay C Jha, Karin A M Jandeleit-Dahm, Mark E Cooper
Pageof 19

Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
Atherosclerosis|September 6, 2017
GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomesYa-Lan Ying, Yung-Chih Chen, Karin Jandeleit-Dahm, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 1, 1993
The kissing balloons technique. Simultaneous dilatation of stenoses of branch arteries at the bifurcation of the renal arteryA Chavan, M Galanski, K Jandeleit, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1991
Angiotensin-converting enzyme in macro- and microvessels of the ratK Jandeleit, B Jackson, R Perich, et al.
Diabetes|November 23, 2013
Comment on: Sukumar et al. Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 2013;62:2130-2134Karin A M Jandeleit-Dahm, Harald H H W Schmidt
Clinical Science (London, England : 1979)|September 1, 2018
A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetesJay C Jha, Florence Ho, Christopher Dan, et al.
Biomedicines|February 27, 2026
Technological Innovations and the Translational Path of Kidney OrganoidsAnni Li, Zhonglin Chai, Karin Jandeleit-Dahm, et al.
Journal of Nephrology|May 25, 2020
Targeting oxidative stress and anti-oxidant defence in diabetic kidney diseaseJakob Appel Østergaard, Mark Emmanuel Cooper, Karin Agnes Maria Jandeleit-Dahm
Current Opinion in Lipidology|January 13, 2009
Direct antiatherosclerotic effects of PPAR agonistsKarin A M Jandeleit-Dahm, Anna Calkin, Chris Tikellis, et al.
Antioxidants & Redox Signaling|February 4, 2020
NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic ComplicationsSofia Urner, Florence Ho, Jay C Jha, et al.
Advances in Chronic Kidney Disease|May 1, 2014
New insights into the use of biomarkers of diabetic nephropathyJay C Jha, Karin A M Jandeleit-Dahm, Mark E Cooper
Pageof 19